We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

140 hedge funds and large institutions have $672M invested in Vanda Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 11

84% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 31

57% more call options, than puts

Call options by funds: $27M | Put options by funds: $17.2M

55% more capital invested

Capital invested by funds: $434M → $672M (+$238M)

22% more funds holding

Funds holding: 115 → 140 (+25)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
140
Holders Change
+25
Holders Change %
+21.74%
% of All Funds
3.74%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
36
Increased
57
Reduced
31
Closed
11
Calls
$27M
Puts
$17.2M
Net Calls
+$9.75M
Net Calls Change
+$4.56M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$16.8M
2
OAM
Oxford Asset Management
United Kingdom
+$13.5M
3
AL
AJO LP
Pennsylvania
+$9.15M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.31M
5
BIM
Bogle Investment Management
Massachusetts
+$7.12M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$34.5M
2
Macquarie Group
Macquarie Group
Australia
-$24M
3
PC
Paulson & Co
New York
-$22.7M
4
SCM
Stonepine Capital Management
Oregon
-$9.08M
5
JGC
J. Goldman & Co
New York
-$5.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
51
State Board of Administration of Florida Retirement System
Florida
$1.94M +$362K +26,879 +30%
GTC
52
Ghost Tree Capital
New York
$1.85M +$1.49M +111,000 New
JG
53
Jefferies Group
New York
$1.69M +$456K +33,907 +50%
BA
54
BlackRock Advisors
Delaware
$1.64M +$25.7K +1,907 +2%
Fidelity Investments
55
Fidelity Investments
Massachusetts
$1.61M +$1.3M +96,913 New
EA
56
Emerald Acquisition
Washington
$1.56M +$598K +44,384 +90%
American Century Companies
57
American Century Companies
Missouri
$1.54M +$1.25M +92,700 New
TC
58
TFS Capital
Pennsylvania
$1.45M +$916K +68,044 +362%
CCI
59
Columbus Circle Investors
$1.4M +$237K +17,633 +27%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$1.29M +$10.8K +800 +1%
EI
61
EAM Investors
California
$1.18M +$954K +70,858 New
SCA
62
Secor Capital Advisors
New York
$1.14M +$923K +68,569 New
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$1.11M -$59.2K -4,400 -6%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.05M – – –
Group One Trading
65
Group One Trading
Illinois
$1.04M +$845K +62,772 New
HCM
66
Highbridge Capital Management
New York
$996K +$806K +59,854 New
GC
67
Globeflex Capital
California
$988K +$800K +59,405 New
VEA
68
Virtus ETF Advisers
New York
$957K +$97.6K +7,249 +14%
Citadel Advisors
69
Citadel Advisors
Florida
$899K +$492K +36,531 +209%
CCMU
70
Cheyne Capital Management (UK)
United Kingdom
$865K – – –
Wells Fargo
71
Wells Fargo
California
$838K +$15.5K +1,150 +2%
AC
72
Amici Capital
New York
$832K – – –
Tudor Investment Corp
73
Tudor Investment Corp
Connecticut
$815K +$488K +36,234 +285%
VFA
74
Virtus Fund Advisers
Connecticut
$769K – – –
SO
75
STRS Ohio
Ohio
$735K -$236K -17,500 -28%
1 2
3
4 5

VNDA Hedge Fund Activity: Q3 2016 in Review

140 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q3 2016, worth a combined $672M — up 55% from $434M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new VNDA positions and 11 closed out — a net gain of 25 holders — while 57 added to existing stakes and 31 trimmed.

The largest buyer was Millennium Management, adding an estimated $16.8M. The largest seller was Deerfield Management, cutting an estimated $34.5M.

  • 140 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q3 2016, up from 115 in Q2 2016.
  • Funds reported $672M of Vanda Pharmaceuticals stock for Q3 2016, up 55% quarter-over-quarter.
  • 36 funds opened new Vanda Pharmaceuticals positions in Q3 2016 and 11 closed out, a net change of +25 holders.
  • The largest Vanda Pharmaceuticals buyer in Q3 2016 was Millennium Management, an estimated $16.8M added.
  • The largest Vanda Pharmaceuticals seller in Q3 2016 was Deerfield Management, an estimated $34.5M sold.

Based on aggregated 13F filings for Q3 2016.